Generation Bio Co. (NASDAQ: GBIO) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
Generation Bio Co. (NASDAQ: GBIO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results [Yahoo! Finance]
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting [Yahoo! Finance]